Filing Flows › NRX Pharmaceuticals (NRXP) › Stock forecast & fair value
NRX Pharmaceuticals (NRXP) stock forecast and price target
NRX Pharmaceuticals (NRXP) trades at $2.38. 4 analysts' median price target is $47.00 (20×), from $10.00 to $51.00.
NRX Pharmaceuticals' latest quarter
NRX Pharmaceuticals, Q2 2026: revenue $1.1M, operating margin -590.8%, net loss $16.5M, operating cash flow −$8.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for NRXP stock?
The median of 4 analysts' 12-month targets is $47.00, 20× from $2.38; the range is $10.00 to $51.00. The average rating is strong buy.
Does NRX Pharmaceuticals usually beat earnings estimates?
It beat the consensus EPS estimate in 50% of the quarters on record.
Is NRXP stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.